Trial
NCT00673439
Fondaparinux for the Treatment of Heparin-Induced Thrombocytopenia (HIT)
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Louisville
Collaborators
James Graham Brown Cancer Center
Condition
Heparin-Induced Thrombocytopenia
Intervention
fondaparinux
Why stopped
study terminated due to low accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-11-08